Drug General Information
Drug ID
D01TMQ
Former ID
DCL000733
Drug Name
Bupropion+naltrexone
Synonyms
Contrave (TN)
Drug Type
Small molecular drug
Indication Obesity [ICD9: 278; ICD10:E66] Phase 3 [532233]
Company
Orexigen Therapeutics
Structure
Download
2D MOL

3D MOL

Formula
C13H18ClNO
PubChem Compound ID
Target and Pathway
Target(s) Dopamine reuptake Target Info Inhibitor [536710]
Sodium-dependent noradrenaline transporter Target Info Inhibitor [536710]
Opioid receptor Target Info Antagonist [536710]
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 532233A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013 May;21(5):935-43.
Ref 536710Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.